Ochre Bio and Boehringer enter CLD regenerative therapy deal
Ochre Bio has entered a strategic collaboration with Boehringer Ingelheim to discover and develop new regenerative treatments for treating chronic…
Ochre Bio has entered a strategic collaboration with Boehringer Ingelheim to discover and develop new regenerative treatments for treating chronic…
The US Food and Drug Administration (FDA) has granted approval for ImmunityBio's ANKTIVA, plus Bacillus Calmette-Guérin (BCG), for treating patients…
Ipsen has entered an exclusive global collaboration with Skyhawk Therapeutics for the discovery and development of new small molecules that…
The European Commission (EC) has granted marketing authorisation for Pfizer’s Emblaveo (aztreonam-avibactam), aimed at treating adults with multidrug-resistant infections where…
The US Food and Drug Administration (FDA) has granted fast-track designation to Bayer subsidiary Asklepios BioPharmaceutical’s (AskBio) investigational gene therapy…
Evotec has entered a partnership agreement with Variant Bio aimed at detecting a treatment for ailments caused by fibrosis. The…
Researchers at the National Cancer Institute, a unit of the National Institutes of Health (NIH) in the US, have developed…
The US Food and Drug Administration (FDA) has granted approval for Takeda’s ENTYVIO subcutaneous (SC) administration as a maintenance therapy…
UK-based biotech company Outrun Therapeutics has announced its launch with a $10m seed investment to advance its protein stabilisation pipeline…
Clearmind Medicine has entered an exclusive licensing agreement with the Yissum Research Development Company of the Hebrew University of Jerusalem…